Ipsa Labs Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.37 Cr
as on 16-11-2024
- Company Age 25 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 2.12 Cr
as on 16-11-2024
- Revenue 2.47%
(FY 2023)
- Profit 195.34%
(FY 2023)
- Ebitda 133.07%
(FY 2023)
- Net Worth 0.94%
(FY 2023)
- Total Assets -1.25%
(FY 2023)
About Ipsa Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.37 Cr.
The company has closed loans amounting to ₹2.12 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sapna Arora and Mukesh Arora serve as directors at the Company.
- CIN/LLPIN
U24239DL1999PTC102388
- Company No.
102388
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 1999
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ipsa Labs Private Limited offer?
Ipsa Labs Private Limited offers a wide range of products and services, including Cosmetics, Hair & Beauty Products, Hair Care Products, Common Disease Medicines, Oral Care Products, Ayurvedic, Herbal Oils and Cosmetics, Ayurvedic Cosmetics, Personal Care, Oral Care, Ayurveda Products, Natural Hair & Skin Care.
Who are the key members and board of directors at Ipsa Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Arora  | Managing Director | 01-May-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sapna Arora | Director | 01-May-2000 | Current |
Financial Performance of Ipsa Labs.
Ipsa Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.47% increase. The company also saw a substantial improvement in profitability, with a 195.34% increase in profit. The company's net worth moved up by a moderate rise of 0.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ipsa Labs?
In 2023, Ipsa Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Royale Crown & Teeth Private LimitedActive 20 years 2 daysSapna Arora and Mukesh Arora are mutual person
Arodent Dental Services Private LimitedActive 26 years 26 daysSapna Arora and Mukesh Arora are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Feb 2002 | ₹2.12 Cr | Satisfied |
How Many Employees Work at Ipsa Labs?
Ipsa Labs has a workforce of 13 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ipsa Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ipsa Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
